MedPath
HSA Approval

NORDAZ TABLET 15 mg

SIN01814P

NORDAZ TABLET 15 mg

NORDAZ TABLET 15 mg

June 14, 1988

PHARMACON PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMACON PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N05BA16

nordazepam

Manufacturer Information

PHARMACON PTE LTD

SOPHARTEX - VERNOUILLET

Active Ingredients

NORDAZEPAM

15 mg

Nordazepam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.